BECTON DICKINSON & CO

SEC 4 · Filed

0001628280-26-033022Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date May 8, 2026

Grant, award or other acquisition by Byington Carrie L

Security
Rights to Common Stock Under BD Deferred Compensation Plan
Code
A
Shares
105
Price per share
149.04
Structured facts
{
  "code": "A",
  "date": "2026-05-08",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The securities convert to common stock on a one-for-one basis.",
    "F2": "The securities are distributed following termination of the reporting person\u0027s service as a director, or on the date or dates specified by the reporting person.",
    "F3": "Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.",
    "F4": "Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person."
  },
  "owners": [
    {
      "cik": "0001890265",
      "name": "Byington Carrie L",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "3699",
  "price": "149.04",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Rights to Common Stock Under BD Deferred Compensation Plan",
  "shares": "105",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "105"
}